Lilly to participate in Wells Fargo 20th Annual Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Boston Scientific discloses cybersecurity incident causing global disruption
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
TD Cowen on Eli Lilly (LLY): 'Orfo Successful In ATTAIN-2, Regulatory Submission Underway; Model Updated'
August 26, 2025 1:37 PM EDTTD Cowen analyst Steve Scala reiterated a Buy rating and $960.00 price target on Eli Lilly (NYSE: LLY).
The analyst comments "LLY reported results from the Phase III trial of orforglipron in patients with obesity + T2D (ATTAIN-2). At 72 weeks the highest orfo... More
